PDF
Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination — Worldwide, 2012–2020
Organization: United States Centers for Disease Control (CDC)Published: 2022
"Congenital rubella syndrome, a devastating constellation of birth defects, is caused by rubella infection during pregnancy. Since 2012, rubella-containing vaccine (RCV) introduction efforts have accelerated worldwide, and a 2020 global policy update recommended that introduction efforts use a strategy that leads to elimination.
By 2020, 173 (89%) of 194 countries had introduced RCVs, and 93 (48%) had been verified as having eliminated rubella transmission. Vaccination introduction equity improved substantially among lower income countries, but vaccination coverage remains a concern.
To further progress, it is important the 21 remaining countries introduce rubella vaccine and that all countries enhance vaccination coverage and surveillance to achieve and maintain elimination." - Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination — Worldwide, 2012–2020
Product Type: Report
Category:
Monitoring and Surveillance,Vaccine Monitoring and Surveillance,Vaccination Coverage and Goals,Vaccine Preventable Disease Surveillance,Global Surveillance,Vaccine Preventable Diseases,Communicable Diseases,Rubella Monitoring and SurveillanceVaccine Monitoring and Surveillance
Vaccination Coverage and Goals
Vaccine Preventable Disease Surveillance
Global Surveillance
Vaccine Preventable Diseases
Communicable Diseases
Rubella
Policy Makers
Population: Children (All)
Adolescents
Adults
Region: International
LinkResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.